380 related articles for article (PubMed ID: 34142342)
1. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.
Hasegawa S; Yoneda M; Kurita Y; Nogami A; Honda Y; Hosono K; Nakajima A
Drugs; 2021 Jul; 81(10):1181-1192. PubMed ID: 34142342
[TBL] [Abstract][Full Text] [Related]
2. Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.
Zein CO; Lindor KD
Curr Gastroenterol Rep; 2010 Feb; 12(1):13-22. PubMed ID: 20425480
[TBL] [Abstract][Full Text] [Related]
3. Current and potential treatments for primary biliary cholangitis.
Shah RA; Kowdley KV
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):306-315. PubMed ID: 31806572
[TBL] [Abstract][Full Text] [Related]
4. Drug Therapies for Chronic Cholestatic Liver Diseases.
Wagner M; Fickert P
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():503-527. PubMed ID: 31506007
[TBL] [Abstract][Full Text] [Related]
5. Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.
Gerussi A; D'Amato D; Cristoferi L; O'Donnell SE; Carbone M; Invernizzi P
Ann Hepatol; 2020; 19(1):5-16. PubMed ID: 31771820
[TBL] [Abstract][Full Text] [Related]
6. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
7. Novel and emerging therapies for cholestatic liver diseases.
Goldstein J; Levy C
Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Holtmeier J; Leuschner U
Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of overlap syndromes.
Bunchorntavakul C; Reddy KR
Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
[TBL] [Abstract][Full Text] [Related]
10. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.
Schramm C; Lohse AW
Clin Rev Allergy Immunol; 2005 Apr; 28(2):105-14. PubMed ID: 15879617
[TBL] [Abstract][Full Text] [Related]
11. Current Treatment Options for Primary Biliary Cholangitis.
Wong KA; Bahar R; Liu CH; Bowlus CL
Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of cholestatic liver diseases].
Gatzen M; Pausch J
Med Klin (Munich); 2002 Mar; 97(3):152-9. PubMed ID: 11957790
[TBL] [Abstract][Full Text] [Related]
14. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
16. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.
Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S3-12. PubMed ID: 23141891
[TBL] [Abstract][Full Text] [Related]
18. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Smith T; Befeler AS
Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
[TBL] [Abstract][Full Text] [Related]
19. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
20. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
